Advertisement
Advertisement
TLRY
Tilray Brands, Inc. Common Stock
6.61
USDSponsored
-0.33
-4.83%
Mar 26, 14:35 UTC -4
Open
TLRY Earnings Reports
Positive Surprise Ratio
TLRY beat 5 of 19 last estimates.
26%
Next Report
Date of Next Report
Apr 06, 2026
Estimate for Q3 26 (Revenue/ EPS)
$205.38M
/-$0.14
Implied change from Q2 26 (Revenue/ EPS)
-5.58%
/-65.85%
Implied change from Q3 25 (Revenue/ EPS)
+10.55%
/-85.42%
Tilray Brands, Inc. Common Stock earnings per share and revenue
On Jan 08, 2026, TLRY reported earnings of -0.41 USD per share (EPS) for Q2 26, missing the estimate of -0.20 USD, resulting in a -100.98% surprise. Revenue reached 217.51 million, compared to an expected 215.17 million, with a 1.09% difference. The market reacted with a +0.55% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 7 analysts forecast an EPS of -0.14 USD, with revenue projected to reach 205.38 million USD, implying an decrease of -65.85% EPS, and decrease of -5.58% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.04
Surprise
-64.35%
Cytosorbents Corp.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.09
Surprise
-76.47%
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
What were Tilray Brands, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Tilray Brands, Inc. Common Stock reported EPS of -$0.41, missing estimates by -100.98%, and revenue of $217.51M, 1.09% above expectations.
How did the market react to Tilray Brands, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 0.55%, changed from $9.13 before the earnings release to $9.18 the day after.
When is Tilray Brands, Inc. Common Stock expected to report next?
The next earning report is scheduled for Apr 06, 2026.
What are the forecasts for Tilray Brands, Inc. Common Stock's next earnings report?
Based on 7
analysts, Tilray Brands, Inc. Common Stock is expected to report EPS of -$0.14 and revenue of $205.38M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement